agilon health, inc. (NYSE:AGL) Given Consensus Recommendation of “Hold” by Analysts

agilon health, inc. (NYSE:AGL) has been assigned a consensus rating of “Hold” from the sixteen research firms that are presently covering the company, Marketbeat.com reports. One investment analyst has rated the stock with a sell recommendation, eleven have given a hold recommendation and four have given a buy recommendation to the company. The average twelve-month price target among analysts that have issued a report on the stock in the last year is $9.73.

A number of brokerages have issued reports on AGL. Stifel Nicolaus decreased their target price on agilon health from $10.00 to $9.00 and set a “hold” rating for the company in a research report on Thursday, February 22nd. Royal Bank of Canada cut their price target on agilon health from $11.00 to $8.00 and set an “outperform” rating for the company in a report on Wednesday, February 28th. Jefferies Financial Group reiterated a “hold” rating and set a $6.50 price target (down from $25.00) on shares of agilon health in a report on Monday, February 26th. Wolfe Research lowered agilon health from an “outperform” rating to a “peer perform” rating in a report on Monday, January 8th. Finally, TD Cowen lowered agilon health from an “outperform” rating to a “market perform” rating and cut their price target for the stock from $12.00 to $6.50 in a report on Monday, February 26th.

Hedge Funds Weigh In On agilon health

Several institutional investors have recently modified their holdings of the stock. Counterpoint Mutual Funds LLC acquired a new position in shares of agilon health during the 1st quarter worth about $421,000. Renaissance Capital LLC lifted its holdings in shares of agilon health by 3.0% during the 1st quarter. Renaissance Capital LLC now owns 191,122 shares of the company’s stock valued at $1,166,000 after purchasing an additional 5,551 shares in the last quarter. Nomura Holdings Inc. bought a new position in shares of agilon health during the 4th quarter valued at about $309,000. Vanguard Group Inc. lifted its holdings in shares of agilon health by 0.8% during the 4th quarter. Vanguard Group Inc. now owns 28,576,261 shares of the company’s stock valued at $358,632,000 after purchasing an additional 220,986 shares in the last quarter. Finally, Wellington Management Group LLP lifted its holdings in shares of agilon health by 2.9% during the 4th quarter. Wellington Management Group LLP now owns 42,510,030 shares of the company’s stock valued at $533,501,000 after purchasing an additional 1,191,253 shares in the last quarter.

agilon health Price Performance

NYSE AGL opened at $5.39 on Friday. The stock’s 50-day moving average price is $5.78 and its two-hundred day moving average price is $10.04. The company has a current ratio of 1.51, a quick ratio of 1.51 and a debt-to-equity ratio of 0.05. The company has a market cap of $2.21 billion, a PE ratio of -8.28 and a beta of 0.49. agilon health has a 1 year low of $4.41 and a 1 year high of $28.38.

agilon health (NYSE:AGL) last released its earnings results on Tuesday, February 27th. The company reported ($0.41) earnings per share for the quarter, missing the consensus estimate of ($0.28) by ($0.13). agilon health had a negative net margin of 5.76% and a negative return on equity of 21.74%. The business had revenue of $1.06 billion for the quarter, compared to analysts’ expectations of $1.02 billion. During the same period last year, the firm earned ($0.14) EPS. The company’s revenue was up 71.8% compared to the same quarter last year. On average, analysts predict that agilon health will post -0.35 EPS for the current year.

About agilon health

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.